RESULTS FROM THE FIRST 2 YEARS OF A CLINICAL TRIAL WITH RECOMBINANT DNA-DERIVED HUMAN GROWTH HORMONE (SOMATREM) IN TURNER'S SYNDROME
محفوظ في:
ROSENFELD, R.G., RESULTS FROM THE FIRST 2 YEARS OF A CLINICAL TRIAL WITH RECOMBINANT DNA-DERIVED HUMAN GROWTH HORMONE (SOMATREM) IN TURNER'S SYNDROME. ACTA PAEDIATRICA SCANDINAVICA, no. SUPL. 331 (1987), p. 59-66.
Ref.
1359
الموقع:
SIIS R.386 Depósito (26/29/30)
Palabras clave:
Genética, Síndrome de Turner, Tratamiento
Genética, Síndrome de Turner, Tratamiento
كن أول من يترك تعليقا!